Maersk has signed a global cold chain logistics agreement with pharmaceutical giant Novo Nordisk.
In this new three year agreement A.P. Moller – Maersk will provide Novo Nordisk with cold chain logistics and transportation including ocean services and inland logistics effectively 1st April 2021.
“Transporting pharmaceuticals on a global level is a demanding task with various complexities that require flexible and resilient supply chains as well as digital and eco-friendly solutions.This achievement showcases the rapid transformation of Maersk as a modern end-to-end logistics company with fully controlled assets,” said Vincent Clerc, Executive Vice President and CEO Ocean and Logistics. A.P. Moller – Maersk.
This agreement also includes its participation in reducing the carbon footprint in the transportation industry. Nova Nordisk chose Maersk’s ECO Delivery service, which uses sustainable biofuel to power selected vessels.
Rune Sylow, Corporate Vice President, Strategic Sourcing at Novo Nordisk, said: “Our ambition of achieving zero environmental impact is a cornerstone of our aspiration to be a truly sustainable business. We consider A.P. Moller – Maersk to be the right global distribution partner to secure the steady, environmentally friendly delivery of our high-value shipments and we look forward to the collaboration.”
Maersk is leading in its participation of handling cold chain logistics with its global infrastructure and agreements.